← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
ERIE
ERIE INDEMNITY CO
Valuation N/A
Financial Services Risk 49 · Elevated
Price$245.03
Model IV—
P/IV—
Limited data — see page
ERNA
Ernexa Therapeutics Inc.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$4.17
Model IV—
P/IV—
Market implies +35.2%/yr vs model +15.0% · above model
ERO
Ero Copper Corp.
Valuation N/A
Basic Materials Risk 27 · Moderate
Price$33.68
Model IV—
P/IV—
Limited data — see page
EROK
EagleRock Land, LLC
Valuation N/A
Financial Services
Price$24.00
Model IV—
P/IV—
Limited data — see page
ESLA
Estrella Immunopharma, Inc.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$0.66
Model IV—
P/IV—
Limited data — see page
ESTA
ESTABLISHMENT LABS HOLDINGS INC.
Valuation N/A
Healthcare Risk 68 · High
Price$70.94
Model IV—
P/IV—
Market implies +29.1%/yr vs model +13.6% · above model
ETB
Eaton Vance Tax-Managed Buy-Write Income Fund
Valuation N/A
Unknown
Price$15.54
Model IV—
P/IV—
Limited data — see page
ETG
Eaton Vance Tax-Advantaged Global Dividend Income Fund
Valuation N/A
Unknown
Price$23.39
Model IV—
P/IV—
Limited data — see page
ETH
Grayscale Ethereum Staking Mini ETF
Valuation N/A
Financial Services Risk 32 · Moderate
Price$24.25
Model IV—
P/IV—
Limited data — see page
ETHA
iShares Ethereum Trust ETF
Valuation N/A
Financial Services Risk 32 · Moderate
Price$18.20
Model IV—
P/IV—
Limited data — see page
ETHB
iShares Staked Ethereum Trust ETF
Valuation N/A
Financial Services Risk 58 · Elevated
Price$32.68
Model IV—
P/IV—
Limited data — see page
ETHE
Grayscale Ethereum Staking ETF
Valuation N/A
Financial Services Risk 32 · Moderate
Price$20.42
Model IV—
P/IV—
Limited data — see page
ETJ
Eaton Vance Risk-Managed Diversified Equity Income Fund
Valuation N/A
Unknown
Price$8.32
Model IV—
P/IV—
Limited data — see page
ETO
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
Valuation N/A
Unknown
Price$30.93
Model IV—
P/IV—
Limited data — see page
ETOR
eToro Group Ltd.
Valuation N/A
Financial Services
Price$30.35
Model IV—
P/IV—
Limited data — see page
ETV
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
Valuation N/A
Unknown
Price$15.19
Model IV—
P/IV—
Limited data — see page
ETW
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
Valuation N/A
Unknown
Price$9.65
Model IV—
P/IV—
Limited data — see page
ETX
Eaton Vance Municipal Income 2028 Term Trust
Valuation N/A
Unknown
Price$18.13
Model IV—
P/IV—
Limited data — see page
ETY
Eaton Vance Tax-Managed Diversified Equity Income Fund
Valuation N/A
Unknown
Price$14.19
Model IV—
P/IV—
Limited data — see page
EU
enCore Energy Corp.
Valuation N/A
Basic Materials Risk 46 · Elevated
Price$1.10
Model IV—
P/IV—
Market implies +43.0%/yr vs model +5.0% · above model
EURK
Eureka Acquisition Corp
Valuation N/A
Industrials
Price$11.45
Model IV—
P/IV—
Limited data — see page
EURKR
Eureka Acquisition Corp
Valuation N/A
Industrials
Price$0.37
Model IV—
P/IV—
Limited data — see page
EVAC
EQV Ventures Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.30
Model IV—
P/IV—
Limited data — see page
EVAX
Evaxion A/S
Valuation N/A
Healthcare Risk 37 · Moderate
Price$3.13
Model IV—
P/IV—
Limited data — see page
EVEX
Eve Holding, Inc.
Valuation N/A
Industrials Risk 60 · High
Price$2.11
Model IV—
P/IV—
Limited data — see page
EVF
Eaton Vance Senior Income Trust
Valuation N/A
Unknown
Price$4.95
Model IV—
P/IV—
Limited data — see page
EVG
Eaton Vance Short Duration Diversified Income Fund
Valuation N/A
Unknown
Price$10.41
Model IV—
P/IV—
Limited data — see page
EVGN
Evogene Ltd.
Valuation N/A
Basic Materials Risk 30 · Moderate
Price$0.48
Model IV—
P/IV—
Limited data — see page
EVN
Eaton Vance Municipal Income Trust
Valuation N/A
Unknown
Price$10.42
Model IV—
P/IV—
Limited data — see page
EVO
Evotec SE
Valuation N/A
Healthcare Risk 54 · Elevated
Price$1.68
Model IV—
P/IV—
Limited data — see page
EVOX
Evolution Global Acquisition Corp
Valuation N/A
Financial Services
Price$10.12
Model IV—
P/IV—
Limited data — see page
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
Valuation N/A
Unknown
Price$28.67
Model IV—
P/IV—
Limited data — see page
EVTL
Vertical Aerospace Ltd.
Valuation N/A
Industrials Risk 58 · Elevated
Price$0.59
Model IV—
P/IV—
Limited data — see page
EVTV
Envirotech Vehicles, Inc.
Valuation N/A
Consumer Cyclical Risk 31 · Moderate
Price$1.80
Model IV—
P/IV—
Market implies +52.3%/yr vs model +8.0% · above model
EVV
Eaton Vance Ltd Duration Income Fund
Valuation N/A
Unknown
Price$8.85
Model IV—
P/IV—
Limited data — see page
EWTX
Edgewise Therapeutics, Inc.
Valuation N/A
Healthcare Risk 30 · Moderate
Price$44.40
Model IV—
P/IV—
Limited data — see page
EXG
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
Valuation N/A
Unknown
Price$9.70
Model IV—
P/IV—
Limited data — see page
EXK
ENDEAVOUR SILVER CORP
Valuation N/A
Basic Materials Risk 27 · Moderate
Price$10.18
Model IV—
P/IV—
Limited data — see page
EXOZ
EXOZYMES INC.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$6.30
Model IV—
P/IV—
Market implies +95.8%/yr vs model +15.0% · above model
EXTR
EXTREME NETWORKS INC
Valuation N/A
Technology Risk 49 · Elevated
Price$22.05
Model IV—
P/IV—
Market implies +27.9%/yr vs model +5.8% · above model
EXYN
Exyn Technologies, Inc.
Valuation N/A
Technology Risk 40 · Elevated
Price$2.52
Model IV—
P/IV—
Limited data — see page
FABC
Fabric.AI, Inc.
Valuation N/A
Communication Services Risk 31 · Moderate
Price$2.43
Model IV—
P/IV—
Market implies +53.1%/yr vs model +15.0% · above model
FACT
FACT II Acquisition Corp.
Valuation N/A
Industrials
Price$10.72
Model IV—
P/IV—
Limited data — see page
FAMI
Farmmi, Inc.
Valuation N/A
Consumer Defensive Risk 46 · Elevated
Price$0.13
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
FANG
Diamondback Energy, Inc.
Valuation N/A
Energy Risk 33 · Moderate
Price$204.97
Model IV—
P/IV—
Market implies -4.4%/yr vs model +8.0% · below model
FATE
FATE THERAPEUTICS INC
Valuation N/A
Healthcare Risk 39 · Moderate
Price$2.31
Model IV—
P/IV—
Market implies +92.2%/yr vs model +2.0% · above model
FATN
Fatpipe Inc/UT
Valuation N/A
Technology Risk 27 · Moderate
Price$5.65
Model IV—
P/IV—
Market implies +26.9%/yr vs model +3.7% · above model
FAX
ABRDN ASIA-PACIFIC INCOME FUND, INC.
Valuation N/A
Unknown
Price$14.42
Model IV—
P/IV—
Limited data — see page
FBIOP
Fortress Biotech, Inc.
Valuation N/A
Healthcare Risk 41 · Elevated
Price$18.45
Model IV—
P/IV—
Market implies +29.3%/yr vs model +5.5% · above model
FBLG
FibroBiologics, Inc.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$1.61
Model IV—
P/IV—
Limited data — see page
FBRX
Forte Biosciences, Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$76.99
Model IV—
P/IV—
Limited data — see page
FCNCN
FIRST CITIZENS BANCSHARES INC /DE/
Valuation N/A
Financial Services Risk 36 · Moderate
Price$23.49
Model IV—
P/IV—
Limited data — see page
FCNCO
FIRST CITIZENS BANCSHARES INC /DE/
Valuation N/A
Financial Services Risk 36 · Moderate
Price$19.73
Model IV—
P/IV—
Limited data — see page
FCNCP
FIRST CITIZENS BANCSHARES INC /DE/
Valuation N/A
Financial Services Risk 36 · Moderate
Price$19.30
Model IV—
P/IV—
Limited data — see page
FCRS
FutureCrest Acquisition Corp.
Valuation N/A
Financial Services
Price$10.27
Model IV—
P/IV—
Limited data — see page
FCT
FIRST TRUST SENIOR FLOATING RATE INCOME FUND II
Valuation N/A
Unknown
Price$9.70
Model IV—
P/IV—
Limited data — see page
FCUV
FOCUS UNIVERSAL INC.
Valuation N/A
Healthcare Risk 34 · Moderate
Price$5.70
Model IV—
P/IV—
Market implies +55.0%/yr vs model +2.0% · above model
FDUS
FIDUS INVESTMENT Corp
Valuation N/A
Unknown Risk 60 · High
Price$19.57
Model IV—
P/IV—
Limited data — see page
FEAM
5E Advanced Materials, Inc.
Valuation N/A
Basic Materials Risk 27 · Moderate
Price$1.33
Model IV—
P/IV—
Market implies +40.8%/yr vs model +5.0% · above model
FEBO
Fenbo Holdings Ltd
Valuation N/A
Technology Risk 57 · Elevated
Price$0.74
Model IV—
P/IV—
Market implies +12.3%/yr vs model -7.2% · above model